Åsa Hillsten has been appointed SVP and Head of IR at BICO and will be a member of the company’s executive management This newly created position constitutes a step in BICO’s continued efforts to increase the service level to the market, improve the clarity of its communication and clarify its business model for the investor market.
“I am looking very much forward to adding value on BICO’s continued journey,” says Åsa Hillsten, the newly appointed SVP & Head of IR at BICO. “I find my motivation in scalable business models and the opportunity to work for a group that so clearly contributes to the future of health. My duties will include elucidating the company’s business, technology and future opportunities and managing the market’s expectations. My role also includes developing and ensuring regulatory compliance and clarifying the results generated by BICO for doctors active in the bioscience sector, owners and capital markets.”
